The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Genetics of hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
Weber, J. L., & May, P. E. (1989) · Europe PMC (PubMed Central) · Cited by 3,399
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Litt, M., & Luty, J. A. (1989) · PubMed · Cited by 1,962
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Morphogenetic roles of classic cadherins
Takeichi, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80102-2 · Cited by 1,450
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,303
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Association of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Cadherin-catenin complex: Protein interactions and their implications for cadherin function
Aberle, H., Schwartz, H., & Kemler, R. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<514::aid-jcb4>3.0.co;2-r · Cited by 806
β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
Brabletz, T., Jung, A., Dag, S., Hlubek, F., & Kirchner, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65204-2 · Cited by 671
Mann, B., Gelos, M., Siedow, A., Hanski, M. L., Gratchev, A., Ilyas, M., Bodmer, W. F., Moyer, M. P., Riecken, E. O., Buhr, H. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1603 · Cited by 663
The oncogenic activation of β-catenin
Polakis, P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80003-3 · Cited by 653
Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways
Barth, A. I., Näthke, I. S., & Nelson, W. J. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80122-6 · Cited by 537
Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L. A., Deuel, B., Lew, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14717 · Cited by 519
Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., & Nakamura, Y. (1998) · PubMed · Cited by 514
Aguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Venkatachalam, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4657 · Cited by 449
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
The adenomatous polyposis coli (APC) tumor suppressor
Polakis, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00008-5 · Cited by 433
Koch, A., Denkhaus, D., Albrecht, S., Leuschner, I., von Schweinitz, D., & Pietsch, T. (1999) · PubMed · Cited by 399
Signal transduction by β-catenin
Gumbiner, B. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80104-9 · Cited by 394
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., & Jirtle, R. L. (1995) · Nature Genetics · doi:10.1038/ng1295-447 · Cited by 355
The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression
Gradl, D., Kühl, M., & Wedlich, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5576 · Cited by 355
Kolligs, F. T., Hu, G., Dang, C. V., & Fearon, E. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5696 · Cited by 319
Higashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R. J., Arii, S., & Fujita, J. (2000) · Nature Medicine · doi:10.1038/71600 · Cited by 299
Nakamura, T., Hamada, F., Ishidate, T., Anai, K., Kawahara, K., Toyoshima, K., & Akiyama, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00198.x · Cited by 296
Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295
TCF/LEF factors earn their wings
Clevers, H., & Van de Wetering, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01305-x · Cited by 291
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.
Tsuda, H., Zhang, W. D., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T., & Hirohashi, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6791 · Cited by 289
Orford, K., Orford, C. C., & Byers, S. W. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.855 · Cited by 276
Wong, N., Lai, P., Lee, S.-W., Fan, S., Pang, E., Liew, C.-T., Sheng, Z., Lau, J. W.-Y., & Johnson, P. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65248-0 · Cited by 275
Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
Comprehensive allelotyping of human hepatocellular carcinoma
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A., & Dejean, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201136 · Cited by 274
Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., & Nakamura, Y. (1992) · PubMed · Cited by 268
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
Kanai, Y., Ushijima, S., Hui, A.-M., Ochiai, A., Tsuda, H., Sakamoto, M., & Hirohashi, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<355::aid-ijc8>3.0.co;2-x · Cited by 253
p53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Allelotype study of primary hepatocellular carcinoma
藤森, 実. (1991) · Medical Entomology and Zoology · doi:10.11501/3089422 · Cited by 221
Hypermethylation of tumor suppressor genes in cancer
Herman, J. G. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0138 · Cited by 218
Kusano, N., Shiraishi, K., Kubo, K., Oga, A., Okita, K., & Sasaki, K. (1999) · Hepatology · doi:10.1002/hep.510290636 · Cited by 208
p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
Matsuda, Y., Ichida, T., Matsuzawa, J., Sugimura, K., & Asakura, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70137-x · Cited by 202
Souza, A. T. D., Hankins, G. R., Washington, M. K., Fine, R. L., Orton, T. C., & Jirtle, R. L. (1995) · PubMed · Cited by 187
Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquet, V, Brechot, C., Redeker, A., & Govindarajah, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8852 · Cited by 184
High frequency of p16INK4A gene alterations in hepatocellular carcinoma
Liew, C. T., Li, H.-M., Lo, K.-W., Leow, C. K., Chan, J. Y., Hin, L. Y., Lau, W. Y., Lai, P. B. S., Lim, B. K., Huang, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202359 · Cited by 180
Activation of β-catenin in epithelial and mesenchymal hepatoblastomas
Wei, Y., Fabre, M., Branchereau, S., Gauthier, F., Perilongo, G., & Buendia, M.-A. (2000) · Oncogene · doi:10.1038/sj.onc.1203356 · Cited by 172
Lunn, R. M., Zhang, Y. J., Wang, L., Chen, C., Lee, P., Lee, C. S., Tsai, W. Y., & Santella, R. M. (1997) · PubMed · Cited by 170
Zhang, X., Xu, H. J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S., Benedict, W. F., & Sekiya, T. (1994) · PubMed · Cited by 168
Smad2 and Smad4 gene mutations in hepatocellular carcinoma
Yakicier, M. C., Irmak, M. B., Romano, A., Kew, M., & Ozturk, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202866 · Cited by 167
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Scorsone, K. A., Zhou, Y. Z., Butel, J. S., & Slagle, B. L. (1992) · PubMed · Cited by 162
Genetic heterogeneity of hepatocellular carcinoma.
Unsal, H., Yakicier, C., Marçais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K. J., & Ozturk, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.822 · Cited by 161
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 151
Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., & Maeda, S. (1994) · PubMed · Cited by 135
Boige, V., Laurent‐Puig, P., Fouchet, P., Fléjou, J., Monges, G., Bédossa, P., Bioulac‐Sage, P., Capron, F., Schmitz, A., Olschwang, S., et al. (1997) · PubMed · Cited by 132
Terris, B., Pineau, P., Brégeaud, L., Valla, D. C., Belghiti, J., Tiollais, P., Degott, C., & Dejean, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203051 · Cited by 131
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., & Sugimachi, K. (1993) · PubMed · Cited by 123
Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., & Thorgeirsson, S. S. (1994) · PubMed · Cited by 123
Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis
Devereux, T. R., Anna, C. H., Foley, J. F., White, C. M., Sills, R. C., & Barrett, J. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202858 · Cited by 123
PTEN/MMAC1 mutations in hepatocellular carcinomas
Yao, Y. J., Ping, X. L., Zhang, H., Chen, F. F., Lee, P. K., Ahsan, H., Chen, C., Lee, P., Peacocke, M., Santella, R. M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202659 · Cited by 121
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.
Qin, L., Tang, Z., Sham, J. S. T., C, Z., Ye, S., Zhou, X., Wu, Z.-Q., Trent, J. M., & Guan, X. (1999) · PubMed · Cited by 118
Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma
Zhang, W., Hirohashi, S., Tsuda, H., Shimosato, Y., Yokota, J., Terada, M., & Sügimura, T. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02534.x · Cited by 114
Nishida, N., Fukuda, Y., Kokuryu, H., Sadamoto, T., Isowa, G., Honda, K., Yamaoka, Y., Ikenaga, M., Imura, H., & Ishizaki, K. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510605 · Cited by 112
Pineau, P., Nagai, H., Prigent, S., Yu, W., Gyapay, G., Weissenbach, J., Tiollais, P., Buendia, M., & Dejean, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202648 · Cited by 108
Honda, K., Sbisà, E., Tullo, A., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.126 · Cited by 105
β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma
Kondo, Y., Kanai, Y., Sakamoto, M., Genda, T., Mizokami, M., Ueda, R., & Hirohashi, S. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00712.x · Cited by 102
p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from thailand
Hollstein, M. C., Wild, C. P., Bleicher, F., Chutimataewin, S., Harris, C. C., Srivatanakul, A., & Montesano, R. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530111 · Cited by 98
Analysis of the P53 Tumor–Suppressor Gene in Hepatocellular Carcinomas From Britain
Challen, C., Lunec, J., Warren, W., Collier, J. D., & Bassendine, M. F. (1992) · Hepatology · doi:10.1002/hep.1840160610 · Cited by 98
Vautier, G., Bomford, A. B., Portmann, B. C., Metivier, E. M., Williams, R. L., & Ryder, S. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70562-7 · Cited by 88
Chaubert, P., Gayer, R., Zimmermann, A., Fontolliet, C., Stamm, B., Bosman, F. T., & Shaw, P. H. (1997) · Hepatology · doi:10.1002/hep.510250613 · Cited by 88
p53 Mutations in human hepatocellular carcinomas from Germany.
Kress, S., Jahn, U.-R., Buchmann, A., Bannasch, P., & Schwarz, M. (1992) · PubMed · Cited by 88
Lin, Y., Sheu, J., Liu, L.-Y., Chen, C.-H., Lee, H.-S., Huang, G., Wang, J., Lee, P., & Lu, F. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00205-1 · Cited by 88
Rashid, A., Wang, J.-S., Qian, G.-S., Lu, B.-X., Hamilton, S. R., & Groopman, J. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690321 · Cited by 87
Microsatellite instability in European hepatocellular carcinoma
Salvucci, M., Lemoine, A., Saffroy, R., Azoulay, D., Lepère, B., Gaillard, S. L., Bismuth, H., REYNES, M., & Debuire, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202279 · Cited by 80
Deletion of the E-cadherin gene in hepatitis B virus-positive chinese hepatocellular carcinomas
Slagle, B. L., Zhou, Y.-Z., Birchmeier, W., & Scorsone, K. A. (1993) · Hepatology · doi:10.1002/hep.1840180402 · Cited by 73
Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer
Parada, L. A., Hallén, M., Tranberg, K. ‐., Hägerstrand, I., Bondeson, L., Mitelman, F., & Johansson, B. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199809)23:1<26::aid-gcc5>3.0.co;2-8 · Cited by 71
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis
Ding, S.-F., Habib, N. A., Dooley, J. S., Wood, C. B., Bowles, L., & Delhanty, J. D. A. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.468 · Cited by 67
Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
Sheu, J., Lin, Y.-W., Chou, H.-C., Huang, G.-T., Lee, M., Lin, Y.-H., Huang, S.-Y., Chen, C., Wang, J.-T., Lee, P.-H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690380 · Cited by 64
Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma.
Fujiwara, Y., Monden, M., Mori, T., Nakamura, Y., & Emi, M. (1993) · PubMed · Cited by 60
Kawate, S., Takenoshita, S., Ohwada, S., Mogi, A., Fukusato, T., Makita, F., Kuwano, H., & Morishita, Y. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.1.127 · Cited by 56
Sylla, A., Diallo, M. S., Castegnaro, J.-J., & Wild, C. P. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s1383-5742(99)00046-0 · Cited by 56
p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
Ng, I. O., Chung, L. P., Tsang, S. W. Y., Lam, C.-W., Lai, E. C. S., Fan, S. T., & NG, M. M. (1994) · PubMed · Cited by 56
PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
Kawamura, N., Nagai, H., Bando, K., Koyama, M., Matsumoto, S., Tajiri, T., Onda, M., Fujimoto, J., 植木, 孝., Konishi, N., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00763.x · Cited by 54
Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma
Sakai, K., Nagahara, H., Abe, K., & Obata, H. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb00982.x · Cited by 43
Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H. L., & Manns, M. P. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80199-5 · Cited by 37
Tsujiuchi, T., Tsutsumi, M., Sasaki, Y., Takahama, M., & Konishi, Y. (1999) · PubMed · Cited by 35
p53 Abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons
Kazachkov, Y., Khaoustov, V. I., Yoffe, B., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.10.2207 · Cited by 30
Chromosome abnormalities in peripheral blood cells of hepatitis B virus chronic carriers.
Simón, D., London, T. W., HANN, H.-W. L., & Knowles, B. B. (1991) · PubMed · Cited by 16
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
(1999) · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
Cited by
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Fernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Metadata
- Authors
- Annick Buendia, M.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 10
- Issue
- 3
- Pages
- 185-200
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2149129433
- Cited by
- 329
- References
- 109
- FWCI
- 12.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.